Survival outcomes of FLT3-ITD⁺ AML according to NUP98r status among those who received allogeneic HSCT (n = 28). (A-B) The Kaplan-Meier plots of relapse-free survival (RFS) (A) and overall survival (OS) (B) in NUP98r⁺ and NUP98r⁻ patients. Statistical analysis was done with IBM SPSS Statistics software version 28.0.0.0. P values <.05 were considered statistically significant. RFS was determined from the time of AML diagnosis to the first relapse, death, or last follow-up. OS was measured from the time of initial diagnosis to death from any cause or last follow-up.